Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin - Concepedia

Concepedia

Publication | Closed Access

Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin

32

Citations

18

References

2005

Year

Leonel Torres, Alejandro Perera, Juan F. Batista, Abel Hern ndez, Tania Crombet, Mayra Ramos, Elia Neninger, M. P eacute rez, Elvia L. S nchez, Susana Romero,

Nuclear Medicine Communications

Abstract

The results of this study suggest that Tc-h-R3 could be used in patients in a safe and effective way, for the diagnosis of epithelial-derived tumours at the two evaluated dose levels.

References

	Year	Citations

Page 1